KeyBanc, Morgan Stanley Slash Price Target On Colfax

  • Colfax Corp's CFX price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer multiples.
  • The analyst maintained an Overweight rating on CFX shares.
  • RelatedColfax's Q4 Earnings
  • Morgan Stanley also lowered its price target on Colfax to $41 (an upside of 11%) from $45 while maintaining the Equal-Weight ratings on the shares.
  • Colfax recently announced the future composition of the board of the company, which will be renamed Enovis Corp., upon the consummation of the company's previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corp.
  • Colfax revealed an expected completion date of April 4, 2022, for the spin-off of ESAB Corp.
  • Price Action: CFX shares are trading higher by 1.97% at $36.77 on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorNewsPrice TargetReiterationAnalyst RatingsMoversTrading IdeasBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!